Close Menu

cell-based diagnostics

Its technology called CELx uses a patient's tumor cells to identify abnormal cellular activity driving their cancer and the most appropriate therapy.

The firm registered the Novaprep HQ+ Orange vial as a class I device with the US FDA, while the CFDA approved the Novaprep system for non-gynecological testing.